Association of SGLT2 inhibitors with post-ablation atrial fibrillation recurrence in individuals with heart failure or type 2 diabetes mellitus: a systematic review and meta-analysis. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.